IXHL vs CNTX
Comparison between Incannex Healthcare Inc (IXHL, Company) and Context Therapeutics Inc (CNTX, Company).
Both IXHL and CNTX are from the Healthcare sector.
IXHL vs CNTX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
IXHL
$43M
CNTX
$43M
Max Drawdown
IXHL
99.03%
Winner
CNTX
93.93%
Sharpe Ratio
IXHL
-0.40
Winner
CNTX
0.01
5Y Beta
Winner
IXHL
0.32
CNTX
0.78
Industry
IXHL
Drug Manufacturers - Specialty & Generic
CNTX
Biotechnology
P/E Ratio
IXHL
-0.51
Winner
CNTX
-0.94
Forward P/E
IXHL
3.78
CNTX
N/A
PEG Ratio
IXHL
N/A
CNTX
-0.05
Debt to Equity
IXHL
0.00%
CNTX
0.00%
Free Cash Flow Yield
Winner
IXHL
-40.88%
CNTX
-78.81%
P/S Ratio
IXHL
7764.11
CNTX
N/A
P/B Ratio
Winner
IXHL
0.50
CNTX
1.09
IXHL vs CNTX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
IXHL
+11.21%
CNTX
-20.62%
3M
Winner
IXHL
-1.92%
CNTX
-79.16%
6M
Winner
IXHL
-57.48%
CNTX
-77.67%
1Y
IXHL
-73.99%
Winner
CNTX
-43.17%
5Y(CAGR)
IXHL
N/A
CNTX
-38.14%
Max(CAGR)
IXHL
-78.65%
Winner
CNTX
-38.14%
IXHL vs CNTX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | IXHL | CNTX |
|---|---|---|
| 2026 | -69.49% | -67.74% |
| 2025 | -82.23% | +23.53% |
| 2024 | -51.82% | -15.32% |
| 2023 | -41.93% | +67.63% |
| 2022 | N/A | -76.89% |
| 2021 | N/A | -47.84% |
IXHL vs CNTX Drawdown Comparison
The maximum drawdown for IXHL was -99.03%, occurring on May 12, 2025. This drawdown has not yet recovered.
The maximum drawdown for CNTX was -93.93%, occurring on Aug 10, 2026. This drawdown has not yet recovered.
The current IXHL drawdown is -98.64%. The current CNTX drawdown is -93.29%.
| Rank | IXHL | CNTX |
|---|---|---|
| #1 | -99.03% Dec 5, 2023 - May 12, 2025 | -93.93% Oct 25, 2021 - Aug 10, 2026 |
| #2 | -34.54% Nov 30, 2023 - Dec 5, 2023 | N/A |
Correlation
Correlation between IXHL and CNTX is -0.04 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.04
-101
Select Stocks to Compare
Popular: IXHL vs SPYCNTX vs SPY
More Comparisons
Compare with similar stocks